Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Asthma | R-HSA-444620 | map05310 | atovaquone | 73078 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | atovaquone | 73078 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | atovaquone | 73078 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | atovaquone | 73078 | drug-path |
| Taste transduction | R-HSA-162582 | map04742 | atovaquone | 73078 | drug-path |
| Cell cycle | R-HSA-1640170 | map04110 | atovaquone | 73078 | drug-path |
| Cardiac muscle contraction | R-HSA-397014 | map04260 | atovaquone | 73078 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | atovaquone | 73078 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | atovaquone | 73078 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | atovaquone | 73078 | drug-path |
| ABC transporters | R-HSA-1369007 | map02010 | atovaquone | 73078 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | strophanthidin | 6185 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | strophanthidin | 6185 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | strophanthidin | 6185 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | strophanthidin | 6185 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | strophanthidin | 6185 | drug-path |
| Asthma | R-HSA-444620 | map05310 | strophanthidin | 6185 | drug-path |
| TGF-beta signaling pathway | R-HSA-168638 | map04350 | strophanthidin | 6185 | drug-path |
| Toll-like receptor signaling pathway | R-HSA-168898 | map04620 | strophanthidin | 6185 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | strophanthidin | 6185 | drug-path |